Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study

QR Code

Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study

Aim of investigation. Comparative assessment of efficacy and safety of Pegaltevir and PegIntron in within pattern of combined antiviral therapy in previously untreated patients with chronic hepatitis C.Material and methods. Overall 140 patients with chronic hepatitis C, who received no antiviral the...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. T. Ivashkin, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, M. V. Mayevskaya, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda
Format:	Article
Language:	Russian
Published:	Gastro LLC 2014-07-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	chronic hepatitis c treatment peginterferon alpha-2b pegaltevir
Online Access:	https://www.gastro-j.ru/jour/article/view/1090
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
by: Marina V. Mayevskaya, et al.
Published: (2018-08-01)

Evolution of antiviral treatment chronic for hepatitis B, C and D
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

DEVELOPMENT AND VALIDATION OF IMMUNOASSAY FOR IMMUNOGENICITY OF INTERFERON-ALPHA 2A DRUGS
by: E. V. Mityushova, et al.
Published: (2019-01-01)

Evaluation of the effectiveness and safety of interferon alpha-2b ointment and gel for prevention of acute respiratory infections in organized groups
by: K. V. Kozlov, et al.
Published: (2024-04-01)

Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C
by: S. N. Batskikh
Published: (2012-11-01)

Aspects of a Methodological Approach to Determination of Interferon Alpha Specific Activity
by: M. L. Baykova, et al.
Published: (2020-03-01)

New diagnostic and treatment perspectives of children’s hepatic lesions
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

Evaluation of the effectiveness of antiviral therapy for coronavirus infection (COVID-19) with the inclusion of recombinant interferon alpha-2b
by: A. V. Mordyk, et al.
Published: (2022-10-01)

Combination of nanosomal form of doxorubicin, interferon alpha, and nitroglycerin in the threatment of 101.8 glioblastoma in Wistar rats
by: V. V. Kudelkina, et al.
Published: (2022-01-01)

INTERLEUKIN-2 – AND INTERFERON-ALPHA- INDUCED CHANGES OF PERIPHERAL BLOOD LYMPHOCYTE SUBPOPULATIONS IN CHILDREN WITH ADVANCED MALIGNANCIES, TREATED WITH CHEMOTHERAPY AND WHOLE BODY HYPERTHERMIA
by: R. S. Ismail-zade, et al.
Published: (2014-07-01)

A Real World Study: Efficacy and Safety of Pegylated Interferon Alpha-2a in Patients with Myeloproliferative Neoplasm
by: Derya Koyun, et al.
Published: (2025-03-01)

Effects of Treatment with Temsirolimus versus Interferon Alpha on Survival of Patients with Metastatic Renal Cell Carcinoma – Single-Center Real-World Experience
by: Ivan Levakov, et al.
Published: (2024-01-01)

The use of combined interferon alpha-2b-based medicine in the complex treatment of herpetic keratitis in patients after coronavirus infection
by: A. V. Surov, et al.
Published: (2023-07-01)

Paradoxical pustular psoriasis induced by tumor necrosis factor inhibitor with elevated interferon-alpha in an ankylosing spondylitis patient: A case report
by: Tinh Khampaen, MD, et al.
Published: (2025-08-01)

Timosin alpha-1 immunomodulating properties
by: M. V. Mayevskaya
Published: (2009-02-01)

USING THE ORIGINAL ALPHA-1-BLOCKERS AND THEIR GENERIC IN CLINICAL UROLOGICAL PRACTICE
by: V. V. Borisov
Published: (2013-09-01)

Vaginal biocenosis in pregnant women with recurrent bacterial vaginosis after treatment with recombinant human interferon alpha-2b
by: A. V. Podgornaya, et al.
Published: (2019-09-01)

Antiviral properties of composition drugs based on double-stranded RNA and human interferon alpha-2b
by: S. G. Gamaley, et al.
Published: (2025-02-01)

Study of Urinary Alpha Glutathione-S-Transferase (Alpha GST) in Children with Idiopathic Nephrotic Syndrome
by: Manal Abdel-Salam, et al.
Published: (2020-08-01)

Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01)

Treatment of chronic hepatitis C by cepeginterferon alpha-2b in combination to ribavirin
by: M. V. Mayevskaya, et al.
Published: (2014-08-01)

Alpha-1 antitrypsin deficiency-associated panniculitis: a case report
by: Špela But, et al.
Published: (2025-06-01)

INFLUENCE OF ALPHA-1-ACID GLYCOPROTEIN UPON PRODUCTION OF CYTOKINES BY PERIPHERAL BLOOD MONONUCLEARS
by: М. V. Osikov, et al.
Published: (2014-07-01)

Antiviral Activity of Double-Stranded Ribonucleic Acid and Interferon Alpha Composition in the Model of Experimental Influenza Infection of Mice
by: S. G. Gamaley, et al.
Published: (2023-12-01)

THE GENE OF ALPHA2A-ADRENORECEPTOR AND ESSENTIAL ARTERIAL HYPERTENSION
by: T. A. Bairova, et al.
Published: (2014-11-01)

ALPHA LABELINGS OF DISJOINT UNION OF HAIRY CYCLES
by: G. Rajasekaran, et al.
Published: (2024-07-01)

CORRECTION OF INTERFERON-α-INDUCED DENDRITIC CELL DYSFUNCTIONS IN IMMUNOCOMPROMISED PATIENTS
by: O. Yu. Leplina, et al.
Published: (2012-05-01)

THE DEPENDENCE OF THE SUCCESS RATE OF ALPHA-TRAINING ON EXTRAVERSION AND NEUROTICISM
by: B. V. Chernyshev, et al.
Published: (2013-04-01)

NEW APPROACHES TO THERAPY OF CLASSICAL PH-NEGATIVE MYELOPROLIFERATIVE DISEASES: THE EXPERIENCE OF EARLY THERAPY WITH CEPEGINTERFERON ALPHA-2B
by: A. S. Polyakov, et al.
Published: (2018-05-01)

Interferons alpha and gamma, pidotimod, and tilorone in the treatment of acute respiratory infections in patients with allergic rhinitis: a prospective, cohort clinical and immunological study
by: O. V. Kalyuzhin, et al.
Published: (2022-07-01)

Immunotoxic effects of interferon alpha-2b, modified by immobilization by means of electron-beam synthesis technology
by: D. N. Kinsht, et al.
Published: (2018-01-01)

Maternal serum Alpha-fetoprotein Level at 12, 22 and 32weeks’ gestation in screening for pre-eclampsia
by: Arwa M. Ahmed, et al.
Published: (2018-08-01)

Autoimmune hepatitis with abnormally high level of serum alpha-fetoprotein (Clinical case)
by: A. O. Bueverov, et al.
Published: (2010-02-01)

Influence of TNF-alpha on the efficacy of anemia correction in patients with lymphoproliferative disorders
by: N. A. Romanenko, et al.
Published: (2022-11-01)

Clinical observation on the efficacy of 35% glycolic acid combined with recombinant human interferon alpha-2β cream for treating facial flat warts
by: HOU Jingmei, et al.
Published: (2025-05-01)

Hemodynamic Reactions during Removal of Brain Tumors with the Combined Use of Fentanyl and Alpha2-Adrenoagonist
by: M. V. Rumyantseva, et al.
Published: (2022-07-01)

GENERALIZED ORDER \((\alpha ,\beta)\) ORIENTED SOME GROWTH PROPERTIES OF COMPOSITE ENTIRE FUNCTIONS
by: Tanmay Biswas, et al.
Published: (2020-12-01)

Interferon Gamma and Tumor Necrosis Factor Alpha Are Inflammatory Biomarkers for Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease
by: Ben Li, et al.
Published: (2025-06-01)